Advertisement
Research Article| Volume 3, ISSUE 1, P61-66, January 2014

Download started.

Ok

NMO spectrum disorders comprise the major portion of CNS inflammatory diseases in Thai patients: A cross sectional study

      Highlights

      • Neuromyelitis optica is more common than multiple sclerosis in Thailand.
      • AQP4-IgG is mandatory for diagnosis in CNS inflammatory disease.
      • AQP4-IgG guides physicians for appropriate management.

      Abstract

      Background

      Neuromyelitis optica (NMO) is more prevalent than multiple sclerosis (MS) in the Asian population. AQP4-IgG as a specific biomarker for NMO has not been systematically validated in Thai patients.

      Objective

      To identify the proportion of central nervous system demyelinating disease of Thai patient in one of referral center and examine its clinico-serological correlation with AQP4-IgG status.

      Method

      Cross sectional collected sera from patients who visited or were admitted to Prasat Neurological Institute from November 2009 to August 2010 were tested for serum AQP4-IgG levels. Patient information was reviewed and diagnoses of MS and clinical isolated syndrome (CIS) were made using the Revised McDonald criteria 2005. Diagnosis of NMO was made using the Revised NMO criteria 2006 (except for AQP4-IgG status) and NMO spectrum disorder (NMOSD) criteria 2007.

      Results

      Sixty-one patients were identified including 12 with NMO, 25 with limited form of NMO, 16 with relapsing remitting MS (RRMS), and 8 with CIS. AQP4-IgG was found in 65% of patients in the NMOSD group. In the MS/CIS group, 2 were AQP4-IgG seropositive. Pleocytosis was significantly higher in the NMOSD group than the MS/CIS group. Cranial MRI revealed that the size and degree of brain lesions were similar in all study groups. However, spinal MRI showed that the MS/CIS groups had a higher prevalence of short segment myelitis and a higher abundance of white matter (p<0.05) than NMOSD group. AQP4-IgG seropositive samples correlated with female patients and the presence of optic neuritis.

      Conclusion

      NMOSD is more common than MS in Thai patients. Moreover, AQP4-IgG is highly specific for NMOSD. Spinal MRI can effectively distinguish NMOSD from MS patients. AQP4-IgG seropositivity is highly correlated with females and the presence of optic neuritis.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Multiple Sclerosis and Related Disorders
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Apiwattanakul M.
        • Popescu B.F.
        • Matiello M.
        • Weinshenker B.G.
        • Lucchinetti C.F.
        • Lennon V.A.
        • et al.
        Intractable vomiting as the initial presentation of neuromyelitis optica.
        Annals of Neurology. 2010; 68: 757-761
        • Kanbayashi T.
        • Shimohata T.
        • Nakashima I.
        • Yaguchi H.
        • Yabe I.
        • Nishizawa M.
        • et al.
        Symptomatic narcolepsy in patients with neuromyelitis optica and multiple sclerosis: new neurochemical and immunological implications.
        Archives of Neurology. 2009; 66: 1563-1566
        • Lennon V.A.
        • Kryzer T.J.
        • Pittock S.J.
        • Verkman A.S.
        • Hinson S.R.
        IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.
        Journal of Experimental Medicine. 2005; 202: 473-477
        • Lennon V.A.
        • Wingerchuk D.M.
        • Kryzer T.J.
        • Pittock S.J.
        • Lucchinetti C.F.
        • Fujihara K.
        • et al.
        A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.
        Lancet. 2004; 364: 2106-2112
        • Milano E.
        • Di Sapio A.
        • Malucchi S.
        • Capobianco M.
        • Bottero R.
        • Sala A.
        • et al.
        Neuromyelitis optica: importance of cerebrospinal fluid examination during relapse.
        Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2003; 24: 130-133
        • Misu T.
        • Fujihara K.
        • Nakashima I.
        • Sato S.
        • Itoyama Y.
        Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica.
        Neurology. 2005; 65: 1479-1482
        • Pittock S.J.
        • Lennon V.A.
        • de Seze J.
        • Vermersch P.
        • Homburger H.A.
        • Wingerchuk D.M.
        • et al.
        Neuromyelitis optica and non organ-specific autoimmunity.
        Archives of Neurology. 2008; 65: 78-83
        • Pittock S.J.
        • Lennon V.A.
        • Krecke K.
        • Wingerchuk D.M.
        • Lucchinetti C.F.
        • Weinshenker B.G.
        Brain abnormalities in neuromyelitis optica.
        Archives of Neurology. 2006; 63: 390-396
        • Pittock S.J.
        • Weinshenker B.G.
        • Lucchinetti C.F.
        • Wingerchuk D.M.
        • Corboy J.R.
        • Lennon V.A.
        Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.
        Archives of Neurology. 2006; 63: 964-968
        • Polman C.H.
        • Reingold S.C.
        • Edan G.
        • Filippi M.
        • Hartung H.P.
        • Kappos L.
        • et al.
        Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”.
        Annals of Neurology. 2005; 58: 840-846
        • Siritho S.
        • Nakashima I.
        • Takahashi T.
        • Fujihara K.
        • Prayoonwiwat N.
        AQP4 antibody-positive Thai cases: clinical features and diagnostic problems.
        Neurology. 2011; 77: 827-834
        • Waters P.J.
        • McKeon A.
        • Leite M.I.
        • Rajasekharan S.
        • Lennon V.A.
        • Villalobos A.
        • et al.
        Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.
        Neurology. 2012; 78 (discussion 9): 665-671
        • Weinshenker B.G.
        • Wingerchuk D.M.
        • Vukusic S.
        • Linbo L.
        • Pittock S.J.
        • Lucchinetti C.F.
        • et al.
        Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis.
        Annals of Neurology. 2006; 59: 566-569
        • Wingerchuk D.M.
        • Lennon V.A.
        • Lucchinetti C.F.
        • Pittock S.J.
        • Weinshenker B.G.
        The spectrum of neuromyelitis optica.
        Lancet Neurology. 2007; 6: 805-815
        • Wingerchuk D.M.
        • Lennon V.A.
        • Pittock S.J.
        • Lucchinetti C.F.
        • Weinshenker B.G.
        Revised diagnostic criteria for neuromyelitis optica.
        Neurology. 2006; 66: 1485-1489